- UK authorises gene therapy for blood disorders in world first Reuters
- UK regulators approve medical treatment involving CRISPR gene editing in world first CNN
- World’s first CRISPR-based medicine wins approval in U.K. STAT
- Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta T Business Wire
- The world’s first gene therapy for sickle cell and thalassemia has been approved The Associated Press
- View Full Coverage on Google News
Read original article here